SCHEDULE 13G

Company

Carisma Therapeutics Inc.

Filed

March 13, 2023

Accession Number

0000894579-23-000135

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →